μ-opioid receptor down-regulation and cAMP-dependent protein kinase pbosphorylation in a mouse model of chronic morphine tolerance

Molecular Brain Research

Volumn 55, Issue 2, 1998, Pages 237-242

  Bernstein, Marissa A ^a   Welch, Sandra P ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

opioid receptor; Antinociception; Morphine; Protein kinase A; Tolerance

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; PLACEBO; RADIOLIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BRAIN STEM; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; IMMUNOASSAY; MALE; MORPHINE TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOWN-REGULATION; DRUG TOLERANCE; INJECTIONS, SUBCUTANEOUS; MALE; MICE; MICE, INBRED ICR; MODELS, BIOLOGICAL; MORPHINE; NALOXONE; PHOSPHORYLATION; RECEPTORS, OPIOID, MU;

EID: 0032052168     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(98)00005-9     Document Type: Article

References (40)

1. Arden J.R., Segredo V., Wang Z., Lameh J., Sadee W. Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged mu-opioid receptor expressed in HEK 293 cells. J. Neurochem. 65:1996;1636-1645.
2. Bernstein M.A., Welch S.P. Effects of spinal versus supraspinal administration of cyclic nucleotide-dependent protein kinase inhibitors on morphine tolerance in mice. Drug Alcohol Depend. 44:1997;41-46.
3. Bhargava H.N., Gulati A. Down-regulation of brain and spinal cord mu-opiate receptors in morphine tolerant-dependent rats. Eur. J. Pharmacol. 190:1990;305-311.
4. 2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice. J. Pharmacol. Exp. Ther. 277:1996;484-490.
5. Chan J.S.C., Chiu T.T., Wong Y.H. Activation of type II adenylyl cyclase by the cloned mu-opioid receptor: coupling to multiple G proteins. J. Neurochem. 65:1995;2682-2689.
6. + channel. J. Biol. Chem. 269:1994;7839-7842.
7. Christie M.J., Williams J.T., North R.A. Cellular mechanisms of opioid tolerance: studies in single brain neurons. Mol. Pharmacol. 32:1987;633-638.
8. D'Amour F.E., Smith D.L. A method of determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72:1941;74-79.
9. Davis M.E., Akera T., Brody T.M. Reduction of opiate binding to brain stem slices associated with the development of tolerance to morphine in rats. J. Pharmacol. Exp. Ther. 211:1979;112-119.
10. Ehrlich Y.H., Bonnet K.A., Davis L.G., Brunngraber E.G. Decreased phosphorylation of specific proteins in neostriatal membranes from rats after long-term narcotic exposure. Life Sci. 23:1978;137-146.
11. Fleming L.M., Ponjee G., Childers S.R. Inhibition of protein phosphorylation by opioid-inhibited adenylyl cyclase in rat brain membranes. J. Pharmacol. Exp. Ther. 260:1992;1416-1424.
12. Guitart X., Hayward M.D., Nisenbaum L.K., Beitner D.B., Haycock J.W., Nestler E.J. Identification of MARPP-58, a morphine- and cyclic AMP-regulated phosphoprotein of 58 kD, as tyrosine hydroxylase: evidence for regulation of its expression by chronic morphine in the rat locus coeruleus. J. Neurosci. 10:1990;2649-2659.
13. Harada H., Ueda H., Katada T., Ui M., Satoh M. Phosphorylated mu-opioid receptor purified from rat brains lacks functional coupling with Gi1, a GTP-binding protein in reconstituted lipid vesicles. Neurosci. Lett. 113:1990;47-49.
14. Harris L.S., Pierson A.K. Some narcotic antagonists in the benzomorphan series. J. Pharmacol. Exp. Ther. 143:1964;141-148.
15. R.A. Harris, H. Yamamoto, H.H. Loh, E.L. Way, Alterations in brain calcium localization during the development of morphine tolerance and dependence, in: H.W. Kosterlitz (Ed.), Opiates and Endogenous Opioid Peptides, Elsevier, New York, 1976, pp. 361-368.
16. 3H-naloxone in the mouse: effect of ions and tolerance development. Life Sci. 14:1974;2393-2399.
17. Keith D.E., Murray S.R., Zaki P.A., Chu P.C., Lissin D.V., Kang L., Evans C.J., von Zastrow M. Morphine activates opioid receptors without causing their rapid internalization. J. Biol. Chem. 271:1996;19021-19024.
18. Law P.Y., Hom D.S., Loh H.H. Opiate receptor down-regulation and desensitization in neuroblastoma×glioma NG108-15 hybrid cells are two separate cellular adaptation processes. Mol. Pharmacol. 24:1983;413-424.
19. Litchfield S.T., Wilcoxon F. A simplified method of evaluating dose effect experiments. J. Pharmacol. Exp. Ther. 96:1949;99-113.
20. m GTPase activity in rat brain: evidence for the involvement of G-proteins in opioid tolerance. Brain Res. Bull. 38:1995;565-568.
21. Mestek A., Hurley J.H., Bye L.S., Campbell A.D., Chen Y., Tian M., Liu J., Schulman H., Yu L. The human mu opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C. J. Neurosci. 15:1995;2396-2406.
22. Nah S.Y., Saya D., Barg J., Vogel Z. Opiate receptor agonists regulate phosphorylation of synapsin I in cocultures of rat spinal cord and dorsal root ganglion. Proc. Natl. Acad. Sci. U.S.A. 90:1993;4052-4056.
23. Narita M., Makimura M., Feng Y., Hoskins B., Ho I.K. Influence of chronic morphine treatment on protein kinase C activity: comparison with butorphanol and implication for opioid tolerance. Brain Res. 650:1994;175-179.
24. Nestler E.J., Tallman J.F. Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus coeruleus. Mol. Pharmacol. 33:1988;127-132.
25. Nye H.E., Nestler E.J. Induction of chronic fos-related antigens in rat brain by chronic morphine administration. Mol. Pharmacol. 49:1996;636-645.
26. Patrick G.A., Dewey W.L., Spaulding T.C., Harris L.S. Relationship of brain morphine levels to analgesic activity in acutely treated mice and rats and in pellet-implanted mice. J. Pharmacol. Exp. Ther. 193:1975;876-883.
27. Patrick G.A., Dewey W.L., Huger F.P., Daves E.D., Harris L.S. Disposition of morphine in chronically infused rats: relationship to antinociception and tolerance. J. Pharmacol. Exp. Ther. 205:1978;556-562.
28. Roach P.J. Multisite and hierarchal protein phosphorylation. J. Biol. Chem. 266:1991;14139-14142.
29. Roy S., Loh H.H. Biological activity of mu opioid receptor. Neuropharmacology. 26:1987;917-921.
30. Scott J.D., McCartney S. Localization of A-kinase through anchoring proteins. Mol. Endocrinol. 8:1994;5-11.
31. Sharma S.K., Klee W.A., Nirenberg M. Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc. Natl. Acad. Sci. U.S.A. 72:1975;3092-3096.
32. 35S]GTPγS autoradiography in rat brain. J. Neurosci. 16:1996;2684-2692.
33. Terwilliger R.Z., Beitner-Johnson D., Sevarino K.A., Crain S.M., Nestler E.J. A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res. 548:1991;100-110.
34. Terwilliger R.Z., Ortiz J., Guitart X., Nestler E.J. Chronic morphine administration increases β-adrenergic receptor kinase (βARK) levels in the rat locus coeruleus. J. Neurochem. 63:1994;1983-1986.
35. Thompson R.C., Mansour A., Akil H., Watson S.J. Cloning and pharmacological characterization of a rat mu opioid receptor. Neuron. 11:1993;903-913.
36. Walsh D.A., van Patten S.M. Multiple pathway signal transduction by the cAMP-dependent protein kinase. FASEB J. 8:1994;1227-1236.
37. 2+-dependent. FEBS Lett. 387:1996;53-57.
38. Yoburn B.C., Billings B., Duttaroy A. Opioid receptor regulation in mice. J. Pharmacol. Exp. Ther. 265:1993;314-320.
39. Zadina J.E., Chang S.L., Ge L.-J., Kastin A.J. Mu opiate receptor down-regulation by morphine and upregulation by naloxone in SH-SY5Y human neuroblastoma cells. J. Pharmacol. Exp. Ther. 265:1993;254-262.
40. Zhang L., Yu Y., Mackin S., Weight F.F., Uhl G.R., Wang J.B. Differential mu opiate receptor phosphorylation and desensitization induced by agonists and phorbol esters. J. Biol. Chem. 271:1996;11449-11454.